EOS imaging is a medical imaging company that is revolutionising the treatment continuum for the most common osteoarticular conditions (hip, knee and spine) and associated orthopaedic surgeries. Its EOS® product is an offshoot of the work by Georges Charpak, a Nobel laureate for physics.
The group has obtained marketing approvals in 32 countries, including the United States (FDA), Canada, Australia and the European Union (CE). The group is headquartered in Paris and has four subsidiaries: in France (Besançon), the United States (Cambridge), Canada (Montreal) and Germany, as well as an office in Singapore.
June 2012: EOS imaging (EOSI) successfully completed its IPO, raising €38 million.
Market capitalisation at IPO date: €120 million